2Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin,1999,49:33-64.
3Minagawa Y, Kigawa J, Irie T, et al. Radical surgery following neoadjuvant chemotherapy for patients with stage ⅢB cervical cancer.Ann Surg Oncol,1998,5:539-543.
4Ivanov S, Zervudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage Ⅰ B and Ⅱ A cervical cancer.Akush Ginekol (Sofiia),2003,42:22-24.
5Toita T, Mitsuhashi N, Teshima T, et al.Postoperative radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol,2004,34:99-103.
6Frei E 3rd. Clinical cancer research: an embattled species. Cancer,1982, 50:1979-1992.
7Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol,2001, 82:88-93.
8Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage ⅠB, ⅡA, and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol,2000, 77:305-309.
9Yamada T, Ohsugi F, Irie T,et al. Extended intraarterial cisplatin infusion for treatment of gynecologic cancer after alteration of intrapelvic blood flow and implantation of a vascular access device. Cardiovasc Intervent Radiol,1996,19:139-145.
10Aoki Y, Tomita M, Sato T, et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol,2001,83:263-267.
